// App-Quantinova.ai

P061 : Neutrophil and Monocyte Cell Numbers Remained Within Normal Limits in Patients with RRMS Treated with Cladribine Tablets 3.5 Mg/Kg (CLARITY/CLARITY EXT.)

Researchers

Presenter

  • Fernando Dangond

Principal Investigators

  • Per Soelberg-Sorensen

  • Ms. Christine Hicking

  • Gavin Giovannoni

Medical Centers

  • 2Danish Multiple Sclerosis Registry, Copenhagen University Hospital København Ø Denmark

  • EMD Serono, Inc, Billerica, MA

  • Merck KGaA, Darmstadt, Germany

  • Queen Mary University of London, William Harvey Research Institute, London, United Kingdom

Locations

  • Denmark

  • United States

  • Germany

  • United Kingdom

Companies

  • EMD Serono Inc.

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Neutropenia

Biomarkers

  • Monocyte

  • Exostosin Glycosyltransferase 1

Drug/Treatment

  • Cladribine

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved